Inventor · disambiguated record
Robert Nussenblatt
Also filed as: NUSSENBLATT ROBERT · NUSSENBLATT ROBERT B
7 granted patents·15 pending applications·658 citations·filing 1989–2025
88Inventor score
Top patents by PatentIndex Score
22 records- 0196US6713081B2Ocular therapeutic agent delivery devices and methods for making and using such devicesUS HEALTH·Filed 2001·Granted Mar 30, 2004·444 cites·18 claims
- 0293US7658364B2Ocular therapeutic agent delivery devices and methods for making and using such devicesUS HEALTH·Filed 2002·Granted Feb 9, 2010·44 cites·18 claims
- 0390US5294604AMethod of treating ocular diseases by periocular administration of cyclosporine A or GUS HEALTH·Filed 1989·Granted Mar 15, 1994·86 cites·16 claims
- 0486US5597567ABlocking cell adhesion molecules and treating animals with ocular inflammationUS HEALTH·Filed 1994·Granted Jan 28, 1997·69 cites·12 claims
- 0585US10709774B2Immunomodulatory pharmaceutical compositionsENZO BIOCHEM INC·Filed 2019·Granted Jul 14, 2020·1 cites·6 claims
- 0684US2024277822A1Methods of treating autoimmune diseaseENZO BIOCHEM INC·Filed 2024·Application pending·0 cites
- 0780US2023364145A1Compositions for Preparing Regulatory T-Cell Compositions for the Treatment of Autoimmune DiseaseENZO BIOCHEM INC·Filed 2023·Application pending·0 cites
- 0876US2010272777A1Ocular therapeutic agent delivery devices and methdos for making and using such devicesUS GOV HEALTH & HUMAN SERV·Filed 2009·Application pending·0 cites
- 0975US2025213709A1Conjugates for treating inflammatory disease and identification of patients likely to benefit from such treatmentUNIV BRISTOL·Filed 2025·Application pending·0 cites
- 1074US2022023402A1Immunomodulatory pharmaceutical compositions including a synthetic peptide and transforming growth factor betaENZO BIOCHEM INC·Filed 2021·Application pending·0 cites
- 1172US11173195B2Immunomodulatory pharmaceutical compositions including a synthetic peptide and transforming growth factor betaENZO BIOCHEM INC·Filed 2020·Granted Nov 16, 2021·0 cites·6 claims
- 1270US2022135692A1Conjugates for treating inflammatory disease and identification of patients likely to benefit from such treatmentUNIV BRISTOL·Filed 2021·Application pending·0 cites
- 1369US2007190111A1Ocular therapeutic agent delivery devices and methods for making and using such devicesUS GOV HEALTH & HUMAN SERV·Filed 2007·Application pending·0 cites
- 1467US2021069247A1Compositions for Preparing Regulatory T-Cell Compositions for the Treatment of Autoimmune DiseaseENZO BIOCHEM INC·Filed 2020·Application pending·0 cites
- 1565US2020231685A1Conjugates for treating inflammatory disease and identification of patients likely to benefit from such treatmentUNIV BRISTOL·Filed 2019·Application pending·0 cites
- 1665US2017232084A1Immune modulation for the treatment of age-related macular degenerationENZO BIOCHEM INC·Filed 2017·Application pending·0 cites
- 1762US2016158146A1Ocular therapeutic agent delivery devices and methods for making and using such devicesUS OF AMERICA DEPT OF HEALTH & HUMAN SERVICES REPRESENTED BY THE SECRETARY C O·Filed 2016·Application pending·0 cites
- 1860US2016296565A1Tolerizing treatments for autoimmune diseaseENZO BIOCHEM INC·Filed 2016·Application pending·0 cites
- 1960US2016333100A1Conjugates for treating inflammatory disease and identification of patients likely to benefit from such treatmentUNIV BRISTOL·Filed 2014·Application pending·0 cites
- 2056US5961977AMethod of treating or preventing autoimmune uveoretinitis in mammalsAUTOIMMUNE INC·Filed 1995·Granted Oct 5, 1999·14 cites·9 claims
- 2137US2014030219A1Methods of diagnosing and treating age-related macular degenerationWEI LAI·Filed 2012·Application pending·0 cites
- 2235US2014044731A1Methods of treating age-related macular degenerationNUSSENBLATT ROBERT·Filed 2012·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Robert Nussenblatt files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →